Japan factory searched over deaths likely linked to supplements

Japan factory searched over deaths likely linked to supplements

/ 03:37 PM March 30, 2024

Japan factory searched over deaths likely linked to supplements

In Japan, health ministry officials head to search a Kobayashi Pharmaceutical Co. factory in Osaka, Japan, on March 30, 2024, in this photo taken by Kyodo. The drugmaker reported five deaths possibly linked to dietary supplements using red yeast rice, an official said. Mandatory credit Kyodo/via REUTERS

TOKYO — Japanese health officials searched a Kobayashi Pharmaceutical factory on Saturday after the drugmaker reported five deaths possibly linked to dietary supplements using red yeast rice, an official said.

The Ministry of Health, Labor and Welfare and the City of Osaka jointly inspected the factory in Osaka that had made the supplements containing “Beni-Koji” red yeast, suspected of having caused health damage, the ministry official said.

Article continues after this advertisement

News footage showed officials entering the factory, and the official said the ministry could search other related locations. The factory, which made the product until December, had been closed due to ageing facilities, Japanese media said.

FEATURED STORIES

READ: Japan dietary supplement maker probes 5 deaths

The Osaka-based company could not immediately be reached for comment. Yuko Tomiyama, head of Kobayashi’s investor relations, told public broadcaster NHK the firm intends to sincerely deal with the matter and fully cooperate with the investigation.

Article continues after this advertisement

Kobayashi said Friday it was investigating a suspected link between the products and their effects on the kidney since it received reports of kidney disease linked to the products.

Article continues after this advertisement

As of Thursday evening, 114 people had been hospitalized and five had died after taking the supplements, which were marketed as helping lower cholesterol levels, according to the company.

Article continues after this advertisement

Kobayashi said it is examining the earnings impact of the latest issues.

READ: US warns of cancer-agent in Japan weight loss pills

Article continues after this advertisement

Japanese Chief Cabinet Secretary Yoshimasa Hayashi criticised the company on Tuesday for its slow response, saying it was regrettable that Kobayashi took two months to announce the health impacts of its products.

The company has been recalling products with Beni-Koji in recent days after receiving reports of kidney ailments. Its products are also consumed in places such as China, and Japanese media said a case of acute renal failure had been reported in Taiwan.

A Chinese consumers association urged consumers to stop using affected products, saying it was concerned about the risk of Kobayashi products, state media reported on Friday.

Beni-Koji contains Monascus purpureus, a red mould that is also used as a red coloring in some foods.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Puberulic acid – a potent antibacterial and antimalarial agent that can be produced from blue mould and can be toxic – was confirmed in a batch of the products that caused health complaints, Japanese media said.

TAGS: Japan, Pharmaceutical industry

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.